Articles Archives - Page 256 of 714

TuesdayMay 31, 2022 11:15 am

Silo Pharma Inc. (SILO) Focuses on Psilocybin’s Anti-Inflammatory Properties

On May 19, 2022, Silo Pharma (OTCQB: SILO) announced that The Translational Psychedelic Research (“TrPR”) Program at UCSF (University of California San Francisco) had “successfully dosed [with psilocybin] patients suffering from Parkinson’s disease.” TrPR connects researchers and medical professionals studying how psychedelics, including psilocybin, ketamine, etc., affect brain functions and other organ systems. Silo Pharma focuses on palliative uses of psychedelics for “PTSD, Parkinson’s, and other rare neurological disorders.” In teaming up with TrPR. Silo is exploring psilocybin’s anti-inflammatory possibilities in patients exhibiting signs of Parkinson’s Disease. Psilocybin’s journey from magic mushrooms to potential life savers has been a long,…

TuesdayMay 31, 2022 10:30 am

Mullen Automotive Inc. (NASDAQ: MULN) Working to Alleviate Consumer Anxiety by Offering EVs with 600-Plus Mile Range

J.D. Power survey reports range was factor most cited in deciding what EV to buy Mullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV space Recognizing the critical role of battery and range in the success of an EV, Mullen is exploring other advanced battery technologies One of the challenges preventing enthusiastic acceptance of electric vehicles is range anxiety, fear that an electric car will run out of battery or fuel before the driver can reach their destination or a charging station. The concern is valid — a January 2022…

TuesdayMay 31, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain

Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issue CYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substance Kernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, following the global pandemic. Already a serious problem before COVID-19, mental health has become even more pressing now, with many companies committed to offering relief to the nearly 1 billion people worldwide who deal with mental-health issues. Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical…

TuesdayMay 31, 2022 9:00 am

Odyssey Group International Inc. (ODYY) Is ‘One to Watch’

Odyssey boasts a diverse development portfolio spanning both pharmaceutical candidates and medical devices The company is evaluating PRV-002 for the treatment of concussion, a dramatically underserved indication that currently has no FDA-approved drug With PRV-001, Odyssey aims to receive Orphan Drug designation, which could potentially accelerate its pathway to FDA approval and provide seven years of market exclusivity CardioMap(R) is intended to provide early, non-invasive testing for heart disease and is being developed for a 510(k) regulatory pathway Save-A-Life is a developmental anti-choking device that Odyssey expects to position as the “accepted” standard and leader in the treatment of choking…

FridayMay 27, 2022 12:00 pm

Crypto Enthusiasts to Gather in Austin, TX for Four-Day 2022 Consensus Festival, Featuring Everything from Blockchain to Web3

Hosted by CoinDesk, the 2022 Consensus festival is slated for June 9-12, 2022, in Austin, Texas The festival features 15,000+ attendees, 400+ speakers, and 250+ event sponsors, catering to all sides of blockchain, crypto, Web3, NFTs and the Metaverse Web3 is the future of the internet – creating a decentralized technology that removes the control from the big tech companies and places it back in the hands of the users Venture Capitalist firm Andreessen Horowitz announced a $4.5 billion fund aimed at Web3; with one third of the funds dedicated exclusively to seed deals Coinbase has become the first crypto-based…

FridayMay 27, 2022 11:15 am

Nowigence Inc. (NOWG) Knowledge Management Tool Distinguishes Itself by Offering Ability to Gather, Organize and Communicate Data

A key to becoming “irreplaceable” is to communicate clearly, Inc. article suggests Nowigence believes the capability to communicate clearly can be found in its high-proprietary, cloud-based knowledge management tool: Pluaris Pluaris reads and analyzes information across the internet 24/7, then organizes and optimizes gathered data for storage, analysis, synthesis and retrieval As companies — and individuals — work to make themselves irreplaceable, an Inc. newsletter notes that communicating clearly is a key skill (https://ibn.fm/0863V). Nowigence’s Inc. (NOWG) Pluaris, a high-proprietary, cloud-based knowledge management tool, makes clear communication easier than ever before. One solution, the article points out, is to distinguish…

FridayMay 27, 2022 10:30 am

Kronos Advanced Technologies Inc. (KNOS) Closes on Milestone Acquisition, Moves Forward with American-Made Manufacturing Plan

Acquisition of 85,000-square-foot West Virginia manufacturing campus is key milestone in company’s vision to become household name Facility checks all boxes company wanted in first design and manufacturing location Kronos is focused on designing and manufacturing next-generation wellness consumer electronics products and PPE solutions A plan started more than two years ago by Kronos Advanced Technologies (OTC: KNOS) is a step closer to fruition today; the company recently announced closed on the acquisition of an 85,000-square-foot West Virginia manufacturing campus that will be retrofitted to produce advanced, proprietary air-purification devices and other wellness products (https://ibn.fm/FQS30). “Nearly two years ago, we…

FridayMay 27, 2022 9:45 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Poised to Capitalize on Opportunities for Sustainable Investing Amid Growing RNG Market

Legislative changes driven by public policy commitment to slashing greenhouse emissions are driving increased demand for renewable natural gas (“RNG”) RNG generation avoids toxic emissions of methane, a greenhouse gas with a warming potential 25–34 times greater than Carbon Dioxide EverGen, Canada’s established renewable natural gas producer, appears ready to act on this rising market opportunity in Canada and beyond; responds with plans to consolidate projects, enter merger, and acquisition transactions, and grow core portfolio projects "We set up EverGen to execute on space that has a tremendous amount of tailwind”, are the words Chase Edgelow, co-founder and CEO of…

FridayMay 27, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging Growing Commercial Opportunities

Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technology The DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastes Lexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applications The company operates several subsidiary companies to focus on different commercial opportunities Ever since acquiring its first intellectual property (“IP”) that subsequently formed the basis of its first two patent application filings in 2014, biotechnology company Lexaria Bioscience (NASDAQ: LEXX) has grown the number of patents granted and…

ThursdayMay 26, 2022 12:00 pm

The Cannabis World Congress & Business Exposition (‘CWCBExpo’) is the Pre-eminent Forum for Gaining a Foothold Within New York’s Fast-Accelerating Cannabis Sector

New York’s recreational and medical marijuana market is poised for historical growth amid rising public and political support for increased cultivation in the tri-state area. The Cannabis World Congress & Business Exposition (“CWCBExpo”), set to take place at New York City’s Javits Convention Center, Hall 3A on June 2-4, 2022, is the ideal forum for exploring industry best practices, business building and networking within this dynamic sector industry. In September 2021, adult New Yorkers could legally possess up to three ounces of cannabis for recreational use or up to 24 grams of concentrated cannabis in certain products such as oils. With the…

Site Search

Company Search

Category: Articles